Jaume Mora

Last updated
Jaume Mora
Jaume Mora Graupera.JPG
Born
NationalitySpanish
Alma mater University of Barcelona, Autonomous University of Barcelona, Memorial Sloan-Kettering Cancer Center,
Known for cancer Completed sequencing of the Ewing's sarcoma, Neuroblastoma, Glioma, Atypical teratoid rhabdoid tumor
Scientific career
Fields Childhood cancer biology
Institutions Hospital Sant Joan de Déu Barcelona
Thesis Molecular genetics of neuroblastoma and the implications for clinical management : towards a biological classification of neuroblastoma tumors  (2003)
Website Official website OOjs UI icon edit-ltr-progressive.svg

Jaume Mora is a Spanish physician and researcher specialized in pediatric cancer.

Contents

Biography

Mora practiced gymnastics in his childhood and youth. [1] He currently lives in Catalonia.

Career

He first studied medicine at the University of Barcelona, where he studied from 1984 to 1990. In 1991 he joined the "Hospital General de Granollers" and in 1992 he joined the "Hospital Universitario Valle de Hebrón", where he became a pediatrician. In 1995 he joined the Medicine School in the Autonomous University of Barcelona, in order to obtain his PhD in 2003. As part of his training, in 1996 he joined the Cornell University Hospital where he specialized in pediatric cancer at the Memorial Sloan Kettering Cancer Center.

Mora is currently Director of the Research Laboratory of Tumor Development and Chief of Pediatric Oncology in the Hospital Sant Joan de Déu Barcelona . [2]

Medical Perspective

For Mora, pediatric oncology's treatments require a constant awareness accompanied by a certain degree of firmness. He has mentioned, repeatedly, that he does not feel gratified with the treatment's result but the process and personalized therapy of each patient. [3] The work and research that he has developed concerning the feasible treatments for cancer have shown that his medical perspective relating to the responsibility of the patient's family, the oncologist and the patient himself have been influenced by commitment, generosity and family strength.

The way he conceives the disease differs from other medical perspectives. For J. Mora, Childhood cancer is better referred to as Developmental cancer. Under this 'Developmental cancer' concept, he refers to an age factor, broadened to include patients up to 25 years old, and also refers to the point in a given patient's development when the cancer might appear. He has established that childhood cancer is a misnomer and that it must be replaced by “Developmental cancer”. For Mora, Developmental cancer is a type of disease that has nothing to do with cancer in adults; he mentions that it is a mistake to compare them because childhood tumors are due to developmental growth only and have nothing to do with external agents. [4]

Medical Contributions

Mora coordinates a group of specialists who research developmental cancer. They have generated the complete sequencing of the Ewing's sarcoma’s genome. In the neuroblastoma, they have gained the ability to predict the tumor’s behavior, and have developed an active plan that will allow the patient a specific therapy. [5] Similarly, they are the first group of researchers to design an animal model of a tumor in the brain stem and have developed a passive treatment without radiation therapy, which can cure gliomas from the spinal cord. [6] In the summer of 2014 they managed to operate a previously inoperable tumor because of its location. The operation was complemented with Mora’s technology and his team printed a tumor model using a 3D printer, allowing them to practice until they were ready to operate on the patient. [7]

Personal Success

Mora establishes that his group of researchers’ success is due to the relationship between the 'laboratory-family', who are still involved with the institution even after the patient's treatment has finished, as that encourages group work and personal passion towards work. Mora mentions that the “laboratory cannot be far away from the patient”, [8] and to ensure a relationship influenced by trust and support as the respective treatments are carried out because at the end of the therapies, all the support received by the patient's family is reflected in financial contributions that enable further research.

Conferences

Conferences’ selection:

Awards

  1. In 2000 ASCO honored him with the recognition young investigator (YIA)
  2. In 2001 ASCO gave him the Career Development Award (CDA)
  3. In 2001 he was awarded with the 16th Schweisguth Prize of the International Society of Pediatric Oncology. (SIOP)
  4. In 2006 the Asociación española en contra del cáncer, gave him the scholarship / award Children First
  5. In 2009 he was awarded with FERO award
  6. In 2011 the BBVA foundation gave him the annual scholarship.

Affiliation

Mora is a member of countless committees. A partial list of these is:

Related Research Articles

<span class="mw-page-title-main">Rhabdomyosarcoma</span> Cancer originating in precursors to muscle cells

Rhabdomyosarcoma (RMS) is a highly aggressive form of cancer that develops from mesenchymal cells that have failed to fully differentiate into myocytes of skeletal muscle. Cells of the tumor are identified as rhabdomyoblasts.

<span class="mw-page-title-main">Roswell Park Comprehensive Cancer Center</span> Hospital in New York, United States

Roswell Park Comprehensive Cancer Center is a cancer research and treatment center located in Buffalo, New York. Founded by surgeon Roswell Park in 1898, the center was the first in the United States to specifically focus on cancer research. The center is usually called Roswell Park in short. The center, which conducts clinical research on cancer as well as the development new drugs, provides advanced treatment for all forms of adult and pediatric cancer, and serves as a member of the National Comprehensive Cancer Network. Roswell Park Comprehensive Cancer Center is as of 2019, the only upstate New York facility to hold the National Cancer Institute designation of "comprehensive cancer center".

<span class="mw-page-title-main">Neuroblastoma</span> Genetically inherited cancer of certain nerve tissues

Neuroblastoma (NB) is a type of cancer that forms in certain types of nerve tissue. It most frequently starts from one of the adrenal glands but can also develop in the head, neck, chest, abdomen, or spine. Symptoms may include bone pain, a lump in the abdomen, neck, or chest, or a painless bluish lump under the skin.

<span class="mw-page-title-main">GD2</span> Chemical compound

GD2 is a disialoganglioside expressed on tumors of neuroectodermal origin, including human neuroblastoma and melanoma, with highly restricted expression on normal tissues, principally to the cerebellum and peripheral nerves in humans.

<span class="mw-page-title-main">Desmoplastic small-round-cell tumor</span> Aggressive and rare cancer

Desmoplastic small-round-cell tumor (DSRCT) is an aggressive and rare cancer that primarily occurs as masses in the abdomen. Other areas affected may include the lymph nodes, the lining of the abdomen, diaphragm, spleen, liver, chest wall, skull, spinal cord, large intestine, small intestine, bladder, brain, lungs, testicles, ovaries, and the pelvis. Reported sites of metastatic spread include the liver, lungs, lymph nodes, brain, skull, and bones. It is characterized by the EWS-WT1 fusion protein.

<span class="mw-page-title-main">Blastoma</span> Type of cancer arising from precursor cells

A blastoma is a type of cancer, more common in children, that is caused by malignancies in precursor cells, often called blasts. Examples are nephroblastoma, medulloblastoma, and retinoblastoma. The suffix -blastoma is used to imply a tumor of primitive, incompletely differentiated cells, e.g., chondroblastoma is composed of cells resembling the precursor of chondrocytes.

The Children's Oncology Group (COG), a clinical trials group supported by the National Cancer Institute (NCI), is the world's largest organization devoted exclusively to pediatric cancer research. The COG conducts a spectrum of clinical research and translational research trials for infants, children, adolescents, and young adults with cancer.

<span class="mw-page-title-main">Medulloblastoma</span> Most common type of primary brain cancer in children

Medulloblastoma is a common type of primary brain cancer in children. It originates in the part of the brain that is towards the back and the bottom, on the floor of the skull, in the cerebellum, or posterior fossa.

<span class="mw-page-title-main">Atypical teratoid rhabdoid tumor</span> Medical condition

An atypical teratoid rhabdoid tumor (AT/RT) is a rare tumor usually diagnosed in childhood. Although usually a brain tumor, AT/RT can occur anywhere in the central nervous system (CNS), including the spinal cord. About 60% will be in the posterior cranial fossa. One review estimated 52% in the posterior fossa, 39% are supratentorial primitive neuroectodermal tumors (sPNET), 5% are in the pineal, 2% are spinal, and 2% are multifocal.

Intraoperative electron radiation therapy is the application of electron radiation directly to the residual tumor or tumor bed during cancer surgery. Electron beams are useful for intraoperative radiation treatment because, depending on the electron energy, the dose falls off rapidly behind the target site, therefore sparing underlying healthy tissue.

Clear cell sarcoma of the kidney (CCSK) is an extremely rare type of kidney cancer comprising 3% of all pediatric renal tumours. Clear cell sarcoma of the kidney can spread from the kidney to other organs, most commonly the bone, but also including the lungs, brain, and soft tissues of the body.

<span class="mw-page-title-main">Oncology</span> Branch of medicine dealing with, or specializing in, cancer

Oncology is a branch of medicine that deals with the study, treatment, diagnosis, and prevention of cancer. A medical professional who practices oncology is an oncologist. The name's etymological origin is the Greek word ὄγκος (ónkos), meaning "tumor", "volume" or "mass". Oncology is concerned with:

<span class="mw-page-title-main">Hope & Heroes Children's Cancer Fund</span> Non-profit organisation in the US

Hope & Heroes is a 501(c)(3) non-profit organization based at Columbia University Medical Center (CUMC) in New York City. Hope & Heroes supports the Division of Pediatric Hematology, Oncology & Stem Cell Transplantation at Columbia University Medical Center. Hope & Heroes funds work on childhood cancer and blood disorders at Columbia University Medical Center—including research, support for families, and care.

<span class="mw-page-title-main">Hospital Sant Joan de Déu Barcelona</span> Hospital in Barcelona, Spain

Hospital Sant Joan de Déu Barcelona is a teaching hospital specializing in the fields of pediatrics, gynecology and obstetrics. It is located on Passeig Sant Joan de Déu in Esplugues de Llobregat, a municipality bordering Barcelona, Catalonia (Spain). It is a privately owned center concerted by the Catalan Health Service which belongs to the Hospitaller Order of St. John of God, religious organization that manages nearly 300 health centers over the world, one of which is St John of God Hospital Sierra Leone.

<span class="mw-page-title-main">Childhood cancer</span> Medical condition

Childhood cancer is cancer in a child. About 80% of childhood cancer cases in high-income countries can be successfully treated via modern medical treatments and optimal patient care. However, only about 10% of children diagnosed with cancer reside in high-income countries where the necessary treatments and care is available. Childhood cancer represents only about 1% of all types of cancers diagnosed in children and adults, but it is often more complex than adult cancers with unique biological characteristics. Its research and treatment is very challenging and limited. For this reason, in countries that are low- and mid-income, childhood cancer is often ignored in control planning, contributing to the burden of missed opportunities for its diagnoses and management.

<span class="mw-page-title-main">Patrick Schöffski</span>

Patrick Schöffski is a German medical doctor specializing in internal medicine, hematology and medical oncology.

<span class="mw-page-title-main">Holger Lode</span> German specialist for pediatrics (born 1967)

Holger Lode is a German specialist for pediatrics. He is Professor and Chair of the Department of General Pediatrics and Pediatric Hematology and Oncology at the University Medicine Greifswald. He is also the director of the Center of Pediatrics and Adolescent Medicine in Greifswald. Lode is well known for his clinical and scientific work on immunotherapy of neuroblastoma.

<span class="mw-page-title-main">Crystal Mackall</span> American physician and immunologist

Crystal L. Mackall is an American physician and immunologist. She is currently the Ernest and Amelia Gallo Family Professor of Pediatrics and Medicine at Stanford University. She is the founding director of the Stanford Center for Cancer Cell Therapy.

Jonathan Lester Finlay is a pediatric neuro-oncologist specializing in the management of children, adolescents and young adults with brain tumors. He is the director of Neuro-oncology at Nationwide Children's Hospital, where he also serves as the Elizabeth and Richard Germain Endowed Chair in Pediatric Cancer. He also is professor of pediatrics at The Ohio State University College of Medicine.

John Matthew Maris is an American pediatric oncologist. He is the Giulio D’Angio Endowed Professor of Pediatrics at the Children's Hospital of Philadelphia (CHOP) and Full Professor at the Perelman School of Medicine at the University of Pennsylvania.

References

  1. "Jaume Mora: "El càncer infantil és una malaltia de tota la família"". Ara.cat. 29 January 2013.
  2. "Jaume Mora". ub.edu. Archived from the original on 2017-02-16. Retrieved 2015-02-02.
  3. "Fundación Sant Joan de Déu". fsjd.org. 9 November 2023.
  4. "Investigació, innovació, ciència i compromís". 9 November 2023.
  5. Mora, Jaume, Muzaffar Akram, and William L. Gerard."Comparison of Normal and Tumor Cells by Laser Campture Microdisection" Methods in Enzymology Academic Press 2002
  6. Mora Graupera, Jaume. "Documentación y archivo del ensayo" chapter 33 MediPharm. Tratado de medicinia Farmacéutica. Editorial Médica Panamericana, 2010
  7. EFE / Barcelona (2 July 2014). "Cirujanos de Sant Joan de Déu extirpan un tumor con una maqueta 3d". El Periódico.
  8. Orden Hospitalaria San Juan de Dios (October 2013). "ISSUU - IN 232 by Orden Hospitalaria San Juan de Dios". Issuu.